Kasidid Lawongsa

Dr. Kasidid Lawongsa

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2024 in Geriatrics & Gerontology International
Verified
Journal Article
Closed access
KLKasidid Lawongsa
Kasidid Lawongsa
PSPatsri Srisuwan
Patsri Srisuwan
STSirakarn Tejavanija
Sirakarn Tejavanija
KGKulachade Gesakomol
Kulachade Gesakomol

29 June 2024 in Cureus
Verified
Journal Article
Open access
KLKasidid Lawongsa
Kasidid Lawongsa
JTJitrawee Tepakorn
Jitrawee Tepakorn
Objectives: This study aimed to investigate the prevalence of sarcopenia among older Thai adults residing in Bangkok and identify associated risk factors. Methods: This cross-sectional study included Thai adults aged >= 60 years. All participants underwent assessments using the Yubi-wakka test, anthropometric measurements, bioelectrical impedance analysis, handgrip strength tests, and physical performance evaluations. Information on demographic characteristics, chronic health conditions, nutritional status, and medication use was also collected. Sarcopenia was diagnosed according to the 2019 Asian Working Group for Sarcopenia criteria. Statistical analyses were performed using the independent t-test, Chi-square test, and logistic regression to identify risk factors. Results: Among the 600 participants, the overall prevalence of sarcopenia was 19%. The multivariate analysis identified 13 significant risk factors associated with sarcopenia, including age >= 75 years (odds ratio [OR]=10.6, 95% confidence interval [CI]=3.7-30.2), higher education level (year) (OR=0.85, 95% CI=0.74-0.98), lower income level (OR=5.4, 95% CI=1.4-21.4), Barthel index <90 (OR=11.0, 95% CI=3.5-34.5), lower body mass index (OR=0.7, 95% CI=0.6-0.8), low calf circumference (OR=7.6, 95% CI=2.5-23.3), fall in the past year (OR, 3.1; 95% CI, 1.4-6.6), frailty (OR, 2.3; 95% CI, 1.1-4.5), malnutrition (OR=3.5, 95% CI=1.3-9.3), history of stroke (OR=7.5, 95% CI=1.3-41.4), vitamin D deficiency (OR=9.4, 95% CI=1.1-82.5), knee osteoarthritis (OR=6.3, 95% CI=1.57-25.31), and malignancy (OR=4.8, 95% CI=1.01-22.70). Conclusion: This study evaluated the sarcopenia status across a diverse demographic of older Thai adults using comprehensive assessments, and examined the impact of socioeconomic factors and various chronic conditions on the occurrence of sarcopenia.


7 February 2026 in Obesity Pillars
Verified
Journal Article
Open access
TLThanapat Limpaarayakul
Thanapat Limpaarayakul
KLKasidid Lawongsa
Kasidid Lawongsa
MPMethavee Poochanasri
Methavee Poochanasri
NSNattapol Sathavarodom
Nattapol Sathavarodom
ABApussanee Boonyavarakul
Apussanee Boonyavarakul
PSParinya Samakkarnthai
Parinya Samakkarnthai
Sarcopenic obesity is an age-related condition characterized by a simultaneous decline in muscle mass and function and by increased adipose tissue. Its prevalence, particularly in Asian populations with type 2 diabetes mellitus (T2DM), remains unclear. This study aimed to determine the prevalence and risk factors associated with sarcopenic obesity in Thai people with T2DM. This cross-sectional, observational study included 329 Thai adults with established type 2 diabetes mellitus (T2DM), consecutively recruited from an outpatient clinic. Participants underwent standardized assessments, including bioelectrical impedance analysis, physical performance testing, and laboratory evaluations. Obesity was defined based on percentage body fat derived from bioelectrical impedance analysis, rather than body mass index. The study aimed to determine the prevalence of sarcopenic obesity and to identify associated risk factors. Univariate and multivariate logistic regression analyses were performed to identify independent predictors after adjustment for potential confounders. The prevalence of sarcopenic obesity in T2DM was 16.4%, with rates of 15.4% in males and 17.5% in females. Sarcopenia was present in 23.7% of participants, including 7.3% with sarcopenia alone (without obesity). Obesity without sarcopenia was reported in 61.1% (95% CI: 55.7, 66.2). Factors significantly associated with a higher risk of sarcopenic obesity included older age (adjusted OR 1.08, 95% CI 1.01–1.15, P < 0.001) and smaller calf circumference (aOR 1.35, 95% CI 1.11–1.67, P < 0.001). Protective factor included greater handgrip strength (aOR 0.93, 95% CI 0.87–0.99, P < 0.001). The study found a high prevalence of sarcopenic obesity among Thai people with T2DM. Older age and smaller calf circumference were identified as key risk factors. Higher muscle strength was associated with a lower risk of developing sarcopenic obesity.

30 June 2024 in Cureus
Verified
Journal Article
Open access
PHParit Hiri-O-Tappa
Parit Hiri-O-Tappa
KLKasidid Lawongsa
Kasidid Lawongsa
SKSupatcha Kengpanich
Supatcha Kengpanich
PSPatsri Srisuwan
Patsri Srisuwan
Objective: This study aims to explore the potential of osteoporosis as a modifiable risk factor for dementia and investigate whether treatments like estrogen supplementation and bisphosphonates can reduce the risk of dementia in the Thai population. This study aimed to evaluate the risk of dementia in patients with osteoporosis. Materials and methods: A cross-sectional analysis was conducted. Participants aged <50 years and those with a history of dementia at baseline were excluded. Clinical variables were analyzed using the chi-squared test. Logistic regression analysis was conducted to determine independent factors of dementia after adjusting for potential confounders. Results: The cohort was conducted on 54,399 participants, of whom 9763 (17.9%) had osteoporosis. The results indicated that individuals with osteoporosis had an odds ratio (OR) of 1.62-fold higher risk of developing dementia compared to those without osteoporosis (95% confidence interval (CI) 1.37-1.92, p-value < 0.001). Furthermore, compared to patients with osteoporosis not undergoing any treatment, those receiving estrogen supplementation and bisphosphonate treatment showed reduced associations with dementia, with an OR of 0.84 (95% CI 0.73-0.98, p-value = 0.023) and 0.66 (95% CI 0.60-0.73, p-value < 0.001), respectively. Conclusion: The study findings suggest an elevated risk of dementia in patients with osteoporosis and contribute substantially to our understanding of the link between osteoporosis and dementia in the Thai population.

14 January 2026 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
KPKraisit Phakwiwat
Kraisit Phakwiwat
KMKorawee Matesareyapong
Korawee Matesareyapong
TLThanapat Limpaarayakul
Thanapat Limpaarayakul
KLKasidid Lawongsa
Kasidid Lawongsa